AlphaCrest Capital Management’s Veracyte VCYT Stock Holding History

AlphaCrest Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,553	Closed	-$676K	–	1449
2021 Q3	$676K	Buy	+14,553	New	+$635K	0.03%	789
2021 Q1	–	Sell	-9,453	Closed	-$463K	–	1315
2020 Q4	$463K	Sell	9,453 -2,147	-19%	-$99.5K	0.04%	694
2020 Q3	$377K	Buy	11,600 +1,847	+19%	+$58.7K	0.04%	745
2020 Q2	$253K	Sell	9,753 -12,447	-56%	-$310K	0.04%	716
2020 Q1	$540K	Buy	22,200 +14,800	+200%	+$373K	0.07%	532
2019 Q4	$207K	Buy	+7,400	New	+$192K	0.02%	1200

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AlphaCrest Capital Management's VCYT Position: Q4 2021 in Review

AlphaCrest Capital Management sold out of Veracyte (VCYT) in Q4 2021, closing a stake of 14,553 shares — an estimated $676K sold.

AlphaCrest Capital Management first reported a position in VCYT in Q4 2019 and held it in 6 quarters. The position peaked at $676K in Q3 2021. 217 funds tracked by Wall St. Rank hold VCYT as of Q4 2021.

AlphaCrest Capital Management reported no remaining Veracyte position as of Q4 2021 after selling out during the quarter.
AlphaCrest Capital Management sold 14,553 Veracyte shares in Q4 2021, an estimated $676K.
AlphaCrest Capital Management first reported a position in Veracyte in Q4 2019 and held it in 6 quarters.
AlphaCrest Capital Management's Veracyte position peaked at $676K in Q3 2021.
217 funds tracked by Wall St. Rank held Veracyte as of Q4 2021.

Based on AlphaCrest Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.